National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting, 30590-30591 [E9-15055]
Download as PDF
30590
Federal Register / Vol. 74, No. 122 / Friday, June 26, 2009 / Notices
Commission’s request for continued
deeming authority for hospitals. This
notice also solicits public comment on
whether the Joint Commission’s
requirements meet or exceed the
Medicare conditions for participation
for hospitals.
III. Evaluation of Deeming Authority
Request
The Joint Commission submitted all
the necessary materials to enable us to
make a determination concerning its
request for reapproval as a deeming
organization for hospitals. This
application was determined to be
complete on May 1, 2009. Under section
1865(a)(2) of the Act and our regulations
at § 488.8 (Federal review of accrediting
organizations), our review and
evaluation of the Joint Commission will
be conducted in accordance with, but
not necessarily limited to, the following
factors:
• The equivalency of the Joint
Commission’s standards for a hospital
as compared with CMS’ hospital
conditions of participation.
• The Joint Commission’s survey
process to determine the following:
—The composition of the survey team,
surveyor qualifications, and the
ability of the organization to provide
continuing surveyor training.
—The comparability of the Joint
Commission’s processes to those of
State agencies, including survey
frequency, and the ability to
investigate and respond appropriately
to complaints against accredited
facilities.
—The Joint Commission’s processes and
procedures for monitoring hospitals
found out of compliance with the
Joint Commission’s program
requirements. These monitoring
procedures are used only when the
Joint Commission identifies
noncompliance. If noncompliance is
identified through validation reviews,
the State survey agency monitors
corrections as specified at § 488.7(d).
—The Joint Commission’s capacity to
report deficiencies to the surveyed
facilities and respond to the facility’s
plan of correction in a timely manner.
—The Joint Commission’s capacity to
provide us with electronic data and
reports necessary for effective
validation and assessment of the
organization’s survey process.
—The adequacy of the Joint
Commission’s staff and other
resources, and its financial viability.
—The Joint Commission’s capacity to
adequately fund required surveys.
—The Joint Commission’s policies with
respect to whether surveys are
VerDate Nov<24>2008
16:39 Jun 25, 2009
Jkt 217001
announced or unannounced, to assure
that surveys are unannounced.
—The Joint Commission’s agreement to
provide us with a copy of the most
current accreditation survey together
with any other information related to
the survey as we may require
(including corrective action plans).
IV. Response to Public Comments and
Notice Upon Completion of Evaluation
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
with a subsequent document, we will
respond to the comments in the
preamble to that document.
Upon completion of our evaluation,
including evaluation of comments
received as a result of this notice, we
will publish a final notice in the Federal
Register announcing the result of our
evaluation.
V. Collection of Information
Requirements
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it need not be reviewed
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 35).
(Catalog of Federal Domestic Assistance
Program No. 93.778, Medical Assistance
Program; No. 93.773 Medicare—Hospital
Insurance Program; and No. 93.774,
Medicare—Supplementary Medical
Insurance Program)
Dated: May 14, 2009.
Charlene Frizzera,
Acting Administrator, Centers for Medicare
& Medicaid Services.
[FR Doc. E9–15183 Filed 6–25–09; 8:45 am]
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Mechanisms of
Practice-Induced Reaching Improvement
after Stroke.
Date: July 17, 2009.
Time: 11:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Peter Zelazowski, PhD,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Rm. 5B01, Bethesda, MD 20892–
7510, 301–435–6902,
peter.zelazowski@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: June 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–15053 Filed 6–25–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4120–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Diabetes and
Digestive and Kidney Diseases;
Amended Notice of Meeting
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Notice is hereby given of a change in
the meeting of the National Institute of
Diabetes and Digestive and Kidney
Diseases Special Emphasis Panel, June
25, 2009, 6 p.m. to June 26, 2009, 5
p.m., Embassy Suites, 1250 22nd Street
NW., Washington, DC 20037 which was
published in the Federal Register on
May 27, 2009, 74 FR 25261.
This meeting will be held on August
3, 2009 from 8:30 a.m. until 5 p.m. The
meeting is closed to the public.
E:\FR\FM\26JNN1.SGM
26JNN1
Federal Register / Vol. 74, No. 122 / Friday, June 26, 2009 / Notices
Dated: June 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–15055 Filed 6–25–09; 8:45 am]
BILLING CODE 4140–01–P
Construction Awards., National Institutes of
Health, HHS)
Dated: June 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–15057 Filed 6–25–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Center for Research
Resources; Notice of Closed Meetings
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
ARRA STRB July Meeting 2.
Date: July 24, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Carol Lambert, PhD,
Scientific Review Officer, Office of Review,
National Institutes of Health, NCRR, 6701
Democracy Blvd., 1 Democracy Plaza, Room
1076, MSC 4874, Bethesda, MD 20892, (301)–
435–0814, lambert@mail.nih.gov.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
ARRA STRB July Meeting 1.
Date: July 24, 2009.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Mohan Viswanathan, PhD,
Scientific Review Officer, National Center for
Research Resources, National Institutes of
Health, One Democracy Plaza, 6701
Democracy Blvd., Room 1084, Bethesda, MD
20892–4874, 301–435–0829, mv10f@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333; 93.702, ARRA Related
VerDate Nov<24>2008
16:39 Jun 25, 2009
Jkt 217001
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Interagency Autism Coordinating
Committee (IACC), part of which will be
a joint meeting between the IACC and
the National Vaccine Advisory
Committee (NVAC).
The meeting will be open to the
public, with attendance limited to space
availability; interested individuals are
encouraged to register early to secure a
space. The meeting will be accessible by
videocast and conference call.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
inform the Contact Person listed below
at least 5 business days in advance of
the meeting.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Date: July 15, 2009.
Time: 8:30 a.m. to 4 p.m.
Agenda: In the morning, the IACC will host
a joint meeting with the NVAC Vaccine
Safety Working Group to discuss vaccine
safety and autism; the afternoon will include
discussion of analysis of the autism research
portfolio and services-related activities.
Public comment periods will be allotted in
both the morning and afternoon sessions.
Place: In Person: Ronald Reagan Building
and International Trade Center, The Polaris
Room (Overflow: The Horizon Room), 1300
Pennsylvania Ave., NW., Washington, DC
20004.
Videocast and conference call information,
as well as Web pre-registration and the
agenda will be available through the IACC
Web site meetings and events page: https://
iacc.hhs.gov/events/.
Contact Person: Ms. Lina Perez, Office of
Autism Research Coordination, Office of the
Director, National Institute of Mental Health,
NIH, 6001 Executive Boulevard, Bethesda,
MD 20892–9669, (301) 443–6040,
IACCPublicInquiries@mail.nih.gov.
Any member of the public interested in
presenting oral comments to the
Committee(s) must notify the Contact Person
listed on this notice at least 10 days in
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
30591
advance of the meeting. Interested
individuals and representatives of
organizations must submit a letter of intent,
a brief description of the organization
represented, and a written/electronic copy of
the oral presentation/statement at least 24
hours in advance of the meeting. A printed/
electronic copy of the comment/statement
provided by the deadline is required prior to
the oral presentation; the document will
become a part of the public record. Only one
representative of an organization will be
allowed to present oral comments and
presentations will be limited to three to five
minutes per speaker, depending on the
number of speakers to be accommodated
within the allotted time. Speakers will be
assigned a time to speak in order of the date
and time when their request to speak is
received, along with the required written
statement submitted at least 24 hours in
advance of the meeting.
In addition, any interested person may
submit written comments to the IACC and/
or the NVAC prior to the meeting by sending
the statement to the Contact Person listed on
this notice at least 24 hours in advance of the
meeting. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person. All
written statements received by the deadline
for both oral and written public comment
will be provided to the IACC (and the NVAC,
if appropriate) for their consideration.
Information about the IACC and a
registration link for this meeting are available
on the IACC Web site: https://
www.iacc.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: June 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–15059 Filed 6–25–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
E:\FR\FM\26JNN1.SGM
26JNN1
Agencies
[Federal Register Volume 74, Number 122 (Friday, June 26, 2009)]
[Notices]
[Pages 30590-30591]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-15055]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute of Diabetes and Digestive and Kidney Diseases Special
Emphasis Panel, June 25, 2009, 6 p.m. to June 26, 2009, 5 p.m., Embassy
Suites, 1250 22nd Street NW., Washington, DC 20037 which was published
in the Federal Register on May 27, 2009, 74 FR 25261.
This meeting will be held on August 3, 2009 from 8:30 a.m. until 5
p.m. The meeting is closed to the public.
[[Page 30591]]
Dated: June 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-15055 Filed 6-25-09; 8:45 am]
BILLING CODE 4140-01-P